USD10
AAPG Shares
About Ascentage Pharma GroupAscentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
USD10
AAPG Shares
About Ascentage Pharma GroupAscentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$1.75B
OPEN PRICE
$19.25
LOW (1Y)
$16.36
HIGH (1Y)
$48.45
LOW (24H)
$18.54
HIGH (24H)
$19.25
VOLUME (24H)
$13.39K
560.3%
Price history
Time | Price | Change |
|---|---|---|
Today | $19.25 | |
1 Day | $18.60 | |
1 Week | $19.01 | |
1 Month | $17.10 | |
1 Year | $39.71 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.


